08:00 , Dec 3, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Latent transforming growth factor β binding protein 3 (LTBP3)

Cardiovascular disease INDICATION: Cardiovascular Mouse studies suggest inhibiting LTBP3 could help treat the cardiovascular pathology of Marfan syndrome, which is associated with high levels of transforming growth factor β (TGFβ) signaling. In a genetic mouse model of...